BIIB
Biogen Inc
NASDAQ · Biotechnology
$201.18
+15.82 (+8.53%)
Performance
1D
—
1W
+12.33%
1M
+8.38%
3M
+26.08%
6M
+48.81%
1Y
+41.14%
YTD
+13.14%
Open$187.01
Previous Close$185.36
Day High$202.41
Day Low$184.60
52W High$202.41
52W Low$110.04
Volume3.40M
Avg Volume1.66M
Market Cap29.51B
P/E Ratio18.35
EPS$10.97
SectorBiotechnology
Volume Analysis
2.05x average volume
Technical Indicators
SMA 50
$177.52
Above
SMA 200
$147.39
Above
RSI (14)
88.6
Overbought
Trend
Golden Cross
Bullish
Analyst Ratings
Hold
42 analysts
Price Target
-54.5% upside
Current
$201.18
$201.18
Target
$91.45
$91.45
$57.23
$91.45 avg
$114.90
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 9.73B | 10.15B | 3.42B |
| Net Income | 1.64B | 1.54B | 884.71M |
| Profit Margin | 16.9% | 16.0% | 25.8% |
| EBITDA | 2.88B | 2.85B | 1.31B |
| Free Cash Flow | — | — | 888.62M |
| Rev Growth | -4.1% | -4.1% | +7.5% |
| Debt/Equity | 0.38 | 0.38 | 1.10 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |